| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 11 |
| 1 | CARBOPLATIN | 9 |
| 2 | PEMBROLIZUMAB | 7 |
| 3 | PREDNISONE | 7 |
| 4 | RITUXIMAB | 7 |
| 5 | ACETAMINOPHEN | 6 |
| 6 | CISPLATIN | 6 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 6 |
| 8 | ETOPOSIDE | 6 |
| 9 | ISONIAZID | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 3 | 0.0014 |
| 1 | PEGCETACOPLAN | 2 | 0.0011 |
| 2 | WHITE PETROLATUM | 1 | 0.0007 |
| 3 | OMAVELOXOLONE | 1 | 0.0006 |
| 4 | PYRAZINAMIDE | 5 | 0.0005 |
| 5 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0005 |
| 6 | SKIN PROTECTANT | 1 | 0.0004 |
| 7 | ISONIAZID | 6 | 0.0004 |
| 8 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Antimycobacterial [EPC] | 6 | 0.0002 |
| 2 | Rifamycin Antibacterial [EPC] | 4 | 0.0001 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |